These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 18172267

  • 1. Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response.
    Gow CH, Chien CR, Chang YL, Chiu YH, Kuo SH, Shih JY, Chang YC, Yu CJ, Yang CH, Yang PC.
    Clin Cancer Res; 2008 Jan 01; 14(1):162-8. PubMed ID: 18172267
    [Abstract] [Full Text] [Related]

  • 2. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.
    Kim YT, Kim TY, Lee DS, Park SJ, Park JY, Seo SJ, Choi HS, Kang HJ, Hahn S, Kang CH, Sung SW, Kim JH.
    Lung Cancer; 2008 Jan 01; 59(1):111-8. PubMed ID: 17904685
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association between EGFR-TKI resistance and efficacy of radiotherapy for brain metastases from EGFR-mutant lung adenocarcinoma.
    Hirata H, Nakamura K, Kunitake N, Shioyama Y, Sasaki T, Ohga S, Nonoshita T, Yoshitake T, Asai K, Inoue K, Nagashima A, Ono M, Honda H.
    Anticancer Res; 2013 Apr 01; 33(4):1649-55. PubMed ID: 23564810
    [Abstract] [Full Text] [Related]

  • 5. A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma.
    Haneda H, Sasaki H, Lindeman N, Kawano O, Endo K, Suzuki E, Shimizu S, Yukiue H, Kobayashi Y, Yano M, Fujii Y.
    Jpn J Clin Oncol; 2006 Feb 01; 36(2):69-75. PubMed ID: 16449241
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
    Suehisa H, Toyooka S, Hotta K, Uchida A, Soh J, Fujiwara Y, Matsuo K, Ouchida M, Takata M, Kiura K, Date H.
    J Clin Oncol; 2007 Sep 01; 25(25):3952-7. PubMed ID: 17761979
    [Abstract] [Full Text] [Related]

  • 7. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
    Rades D, Dunst J, Schild SE.
    Strahlenther Onkol; 2008 May 01; 184(5):251-5. PubMed ID: 18427755
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status.
    Pesek M, Benesova L, Belsanova B, Mukensnabl P, Bruha F, Minarik M.
    Anticancer Res; 2009 Jul 01; 29(7):2767-73. PubMed ID: 19596959
    [Abstract] [Full Text] [Related]

  • 12. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Rades D, Kueter JD, Pluemer A, Veninga T, Schild SE.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1077-81. PubMed ID: 18707817
    [Abstract] [Full Text] [Related]

  • 13. The treatment of single brain metastasis from non-oat cell lung carcinoma. Surgery and radiation versus radiation therapy alone.
    Mandell L, Hilaris B, Sullivan M, Sundaresan N, Nori D, Kim JH, Martini N, Fuks Z.
    Cancer; 1986 Aug 01; 58(3):641-9. PubMed ID: 3731022
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases.
    Ke SB, Qiu H, Chen JM, Shi W, Chen YS.
    Curr Med Sci; 2018 Dec 01; 38(6):1062-1068. PubMed ID: 30536070
    [Abstract] [Full Text] [Related]

  • 15. Gamma knife radiosurgery for multiple brain metastases from lung cancer.
    Park SH, Hwang SK, Kang DH, Lee SH, Park J, Hwang JH, Hamm IS, Park YM.
    J Clin Neurosci; 2009 May 01; 16(5):626-9. PubMed ID: 19268596
    [Abstract] [Full Text] [Related]

  • 16. EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors.
    Sartori G, Cavazza A, Sgambato A, Marchioni A, Barbieri F, Longo L, Bavieri M, Murer B, Meschiari E, Tamberi S, Cadioli A, Luppi F, Migaldi M, Rossi G.
    Am J Clin Pathol; 2009 Apr 01; 131(4):478-89. PubMed ID: 19289583
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.
    Nose N, Sugio K, Oyama T, Nozoe T, Uramoto H, Iwata T, Onitsuka T, Yasumoto K.
    J Clin Oncol; 2009 Jan 20; 27(3):411-7. PubMed ID: 19064969
    [Abstract] [Full Text] [Related]

  • 19. Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site.
    Rades D, Raabe A, Bajrovic A, Alberti W.
    Strahlenther Onkol; 2004 Mar 20; 180(3):144-7. PubMed ID: 14991201
    [Abstract] [Full Text] [Related]

  • 20. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
    Bohlen G, Meyners T, Kieckebusch S, Lohynska R, Veninga T, Stalpers LJ, Schild SE, Rades D.
    Clin Neurol Neurosurg; 2010 Apr 20; 112(3):183-7. PubMed ID: 19962229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.